Study of JDQ443 in Comparison With Docetaxel in Participants With Locally Advanced or Metastatic KRAS G12C Mutant Non-small Cell Lung Cancer
Clinical trial NCT05132075 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT05132075
- Sponsor
- Novartis Pharmaceuticals
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2022-06-15
- Primary completion
- 2026-08-25
- Enrollment
- 95
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.